subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:6NS400BXKH

tested_intervention: unsure


subject: UMLS:C1570308


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents

object_name: Sepsis

tested_intervention: yes


subject: UMLS:C0042397

object_name: Sepsis, CTCAE


subject: CHEBI:41423

subject_name: Celecoxib

object_name: schizophrenia


subject: UMLS:C5565538

subject_name: mazdutide

object_name: Overweight


subject: UMLS:C5565538

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5565538

object_name: obesity


subject: UMLS:C5565538

object_name: Obesity, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: malignant neoplasm of breast stage IIIa


subject: CHEBI:4026

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:15414

subject_name: Adomet

object_name: primary biliary cholangitis


subject: CHEBI:67040

subject_name: Ademetionine


subject: UMLS:C5417993

subject_name: Porustobart

object_name: colorectal cancer


subject: UMLS:C5417993

object_name: colorectal carcinoma


subject: UMLS:C5417993

object_name: neuroendocrine neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Solid Neoplasm


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UNII:8D7B37T28G

subject_name: SATRAPLATIN

object_name: cancer


subject: CHEBI:37845

subject_name: growth hormone

object_name: Congenital IGHD


subject: CHEBI:37845

object_name: Reduced circulating growth hormone concentration


subject: CHEBI:37845

object_name: osteoporosis


subject: CHEBI:37845

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:37845

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:37845

object_name: Osteoporosis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: UMLS:C2346936

subject_name: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

object_name: glioblastoma


subject: UMLS:C2346936

object_name: Childhood Glioblastoma


subject: UMLS:C2346936

object_name: adult glioblastoma


subject: UMLS:C2346936

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C2346936

object_name: Childhood Giant Cell Glioblastoma


subject: UMLS:C2346936

object_name: giant cell glioblastoma


subject: UMLS:C2346936

object_name: Adult Gliosarcoma


subject: UMLS:C2346936

object_name: gliosarcoma


subject: UMLS:C2346936

object_name: Childhood Gliosarcoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: metastatic prostate carcinoma


subject: CHEBI:4672

object_name: Hormone sensitive prostate cancer


subject: CHEBI:4672

object_name: Effects of chemotherapy


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:47344


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:15940

subject_name: Niacin

object_name: systolic heart failure


subject: CHEBI:15940

object_name: Hyperketonemia


subject: CHEBI:15940

object_name: Ketosis


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:22972

subject_name: butyryl group

object_name: rosacea


subject: CHEBI:22927

subject_name: bromine atom


subject: CHEBI:22925

subject_name: bromide salt


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: endocrine exophthalmos


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: disorder of pharynx


subject: CHEBI:31355

subject_name: Carboplatin

object_name: neoplasm of testis


subject: CHEBI:31355

object_name: testicular cancer


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Recurrent Glioblastoma, IDH-Wildtype


subject: UMLS:C0919079

object_name: Recurrent WHO Grade 2 Glioma


subject: UMLS:C0919079

object_name: Recurrent WHO Grade 4 Glioma


subject: UMLS:C0919079

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:231347

subject_name: Triapine


subject: CHEBI:231347


subject: CHEBI:231347


subject: CHEBI:231347


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: UMLS:C2826110


subject: CHEBI:83766

subject_name: Olaparib

object_name: adult lymphoma


subject: CHEBI:83766

object_name: lymphoma


subject: CHEBI:83766

object_name: pediatric lymphoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: scabies


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: schizoaffective disorder


subject: CHEBI:31236

object_name: schizophrenia 18


subject: CHEBI:2469

subject_name: Adefovir

object_name: HIV infection


subject: CHEBI:2469

object_name: cytomegalovirus infection


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:16347


subject: CHEBI:93772

subject_name: Ispinesib

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:93772

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:93772

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:93772

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:93772

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:93772

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:93772

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:93772

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:93772

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:93772

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:93772

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:93772

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:93772

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:93772

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:93772

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:93772

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:93772

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:93772

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:93772

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:93772

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:93772

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:93772

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:93772

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:93772

object_name: stage IVB salivary gland cancer


subject: CHEBI:93772

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:93772

object_name: stage IVA salivary gland cancer


subject: CHEBI:93772

object_name: stage IVC salivary gland cancer


subject: CHEBI:93772

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB17575

object_name: breast carcinoma


subject: DRUGBANK:DB17575

object_name: breast cancer


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Intraoperative blood loss


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: childhood acute monocytic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: acute monocytic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:567361

subject_name: Cladribine


subject: CHEBI:567361


subject: CHEBI:567361


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: UMLS:C1617352

subject_name: INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES, 1 MG

object_name: Pancreas carcinoma resectable


subject: UMLS:C1617352

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C1617352

object_name: pancreatic adenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: DRUGBANK:DB09328

subject_name: Vayarin

object_name: attention deficit hyperactivity disorder, inattentive type


subject: DRUGBANK:DB09328


subject: DRUGBANK:DB09328

object_name: pervasive developmental disorder


subject: DRUGBANK:DB09328

object_name: autism


subject: DRUGBANK:DB09328

object_name: autism spectrum disorder


subject: GTOPDB:13768

subject_name: cagrilintide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: GTOPDB:13768

object_name: obesity


subject: GTOPDB:13768

object_name: Obesity, CTCAE


subject: GTOPDB:13768

object_name: Overweight


subject: CHEMBL.COMPOUND:CHEMBL4802169

subject_name: CAGRILINTIDE


subject: CHEMBL.COMPOUND:CHEMBL4802169


subject: CHEMBL.COMPOUND:CHEMBL4802169


subject: CHEMBL.COMPOUND:CHEMBL4802169


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:38940

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Anorexia


subject: CHEBI:5118

object_name: eating disorder


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: hepatobiliary disorder


subject: UNII:G8RGG88B68

object_name: liver disorder


subject: UNII:G8RGG88B68

object_name: Hypoxemia


subject: UNII:G8RGG88B68

object_name: Blood oxygen concentration below reference range (finding)


subject: UNII:G8RGG88B68

object_name: anemia


subject: UNII:G8RGG88B68

object_name: Anemia, CTCAE


subject: UNII:MLU3LU3EVV

subject_name: Onasemnogene abeparvovec

object_name: spinal muscular atrophy


subject: MESH:C514822

subject_name: oxycodone-acetaminophen

object_name: Post-Operative Pain


subject: MESH:C514822

object_name: Anterior Cruciate Ligament Injuries


subject: UMLS:C0717368

subject_name: acetaminophen / oxycodone


subject: UMLS:C0717368


subject: CHEBI:6121

subject_name: Ketamine

object_name: Ketamine adverse reaction


subject: CHEBI:6121

object_name: Pain, Intractable


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Colon Neoplasm


subject: UMLS:C4287697


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Adult Intracranial Neoplasm


subject: CHEBI:4466

object_name: Adult Solid Neoplasm


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Diastolic dysfunction


subject: CHEBI:9150

object_name: hypertension


subject: CHEBI:9150

object_name: Hypertension, CTCAE


subject: UMLS:C5815593

object_name: retinitis pigmentosa


subject: UMLS:C5815593

object_name: retinitis pigmentosa 1


subject: UMLS:C5780032

subject_name: HUMAN CILIARY NEUROTROPHIC FACTOR


subject: UMLS:C5780032


subject: UNII:BT8F8AD6WO

object_name: Childhood Breast Carcinoma


subject: UNII:BT8F8AD6WO

object_name: breast carcinoma


subject: UNII:BT8F8AD6WO

object_name: breast cancer


subject: UMLS:C4723689

subject_name: antibody-drug conjugate SC-005


subject: UMLS:C4723689


subject: UMLS:C4723689


subject: UNII:EYK815W3Z8

subject_name: Nesbuvir

object_name: liver failure


subject: UNII:EYK815W3Z8

object_name: hepatitis C


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Herpes simplex type II


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:90936

subject_name: Alectinib

object_name: cancer of unknown primary site


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:95089

subject_name: Ipatasertib


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: CHEBI:83766

subject_name: Olaparib


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:66903

subject_name: Vismodegib


subject: GTOPDB:7989

subject_name: sirukumab

object_name: temporal arteritis


subject: CHEMBL.COMPOUND:CHEMBL1743071

subject_name: SIRUKUMAB


subject: UMLS:C3254570


subject: UMLS:C0440016

subject_name: Allergenic extract

object_name: Atopic rhinitis


subject: UMLS:C0440016

object_name: Allergic Rhinitis, CTCAE


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Idiopathic subglottic tracheal stenosis


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Metastatic Colorectal Adenocarcinoma


subject: UNII:L500PR95QA

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UNII:L500PR95QA

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:L500PR95QA

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UNII:L500PR95QA

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UNII:L500PR95QA

object_name: Small intestine adenocarcinoma metastatic


subject: UNII:L500PR95QA

object_name: Stage IV Small Intestinal Adenocarcinoma AJCC v8


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:7507


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: CHEBI:28001


subject: UMLS:C1957666

object_name: non-small cell lung carcinoma


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Muscle Invasive Bladder Carcinoma


subject: MESH:C420918

subject_name: BufferGel

object_name: Pregnant


subject: UMLS:C0964399


subject: CHEBI:34523

subject_name: Acotiamide

object_name: dyspepsia


subject: CHEBI:34523

object_name: Dyspepsia, CTCAE


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine

object_name: streptococcal infection


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: magnesium deficiency


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: migraine with aura


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:46295

subject_name: Vardenafil

object_name: glioma


subject: CHEBI:46295

object_name: malignant glioma


subject: CHEBI:46295

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:46295

object_name: brain cancer


subject: CHEBI:46295

object_name: brain neoplasm


subject: UMLS:C5204488

subject_name: Taurultam Analogue GP-2250

object_name: Pancreatic cancer, adult


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:87631


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:39548


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:7953

subject_name: Pemoline


subject: CHEBI:7953


subject: UMLS:C2698298

subject_name: B7-DC Crosslinking Antibody rHIgM12B7

object_name: skin melanoma


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: tropical spastic paraparesis


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:90936

subject_name: Alectinib

object_name: Anaplastic lymphoma kinase fusion oncogene positive non-small cell lung cancer


subject: UMLS:C2348229

subject_name: NovaSoy

object_name: Alzheimer disease


subject: UMLS:C5557668

object_name: sickle cell disease


subject: CHEBI:8707

subject_name: Quetiapine

object_name: psychosis


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: gastric neoplasm


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4329313


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:91826462

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:41423

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Recurrent Sinonasal Carcinoma


subject: CHEBI:41423

object_name: nasal cavity and paranasal sinus carcinoma


subject: CHEBI:41423

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:41423

object_name: Oropharyngeal cancer recurrent


subject: CHEBI:41423

object_name: Recurrent Oral Cavity Carcinoma


subject: CHEBI:41423

object_name: Relapsed Hypopharynx Carcinoma


subject: CHEBI:41423

object_name: Carcinoma larynx recurrent


subject: CHEBI:41423

object_name: oral cavity carcinoma


subject: UMLS:C5418104

subject_name: Fluorescent Imaging Agent cRGD-ZW800-1

object_name: hypopharynx squamous cell carcinoma


subject: UMLS:C5418104

object_name: laryngeal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:9915131

subject_name: Lapdap

object_name: malaria


subject: PUBCHEM.COMPOUND:9915131

object_name: Fever


subject: PUBCHEM.COMPOUND:9915131

object_name: Fever symptoms (finding)


subject: PUBCHEM.COMPOUND:9915131

object_name: Fever, CTCAE


subject: MESH:C519882

subject_name: chloroguanil, dapsone drug combination


subject: MESH:C519882


subject: MESH:C519882


subject: MESH:C519882


subject: CHEBI:63918

subject_name: Artesunate


subject: CHEBI:63918


subject: CHEBI:63918


subject: CHEBI:27563

subject_name: arsenic atom


subject: CHEBI:27563


subject: CHEBI:27563


subject: CHEBI:27563


subject: CHEBI:233101

subject_name: Ala-Ser


subject: CHEBI:233101


subject: CHEBI:233101


subject: CHEBI:233101


subject: CHEBI:47217

subject_name: arsane


subject: CHEBI:47217


subject: CHEBI:47217


subject: CHEBI:47217


subject: CHEBI:35828


subject: CHEBI:35828


subject: CHEBI:35828


subject: CHEBI:35828


subject: PR:000022165

subject_name: putative sulfatase AslA


subject: PR:000022165


subject: PR:000022165


subject: PR:000022165


subject: MESH:C515299

subject_name: amodiaquine, artesunate drug combination


subject: MESH:C515299


subject: MESH:C515299


subject: MESH:C515299


subject: MESH:C086083


subject: MESH:C086083


subject: MESH:C086083


subject: UMLS:C0936150

subject_name: artemether / lumefantrine


subject: UMLS:C0936150


subject: UMLS:C0936150


subject: CHEBI:73770

subject_name: Ala-Leu


subject: CHEBI:73770


subject: CHEBI:73770


subject: CHEBI:73838

subject_name: D-Ala-Leu


subject: CHEBI:73838


subject: CHEBI:73838


subject: CHEBI:30136

subject_name: Aluminium


subject: CHEBI:30136


subject: CHEBI:30136


subject: CHEBI:28984

subject_name: aluminium atom


subject: CHEBI:28984


subject: CHEBI:28984


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:43805

object_name: Neoplasm Metastasis


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C4045537

object_name: Alzheimer disease type 1


subject: UMLS:C4045537

object_name: Alzheimer disease


subject: UMLS:C4045537

object_name: brain disorder


subject: UMLS:C4045537

object_name: nervous system disorder


subject: UMLS:C4045537

object_name: neurodegenerative disease


subject: UMLS:C4045537

object_name: CNS disorder


subject: UMLS:C4045537

object_name: cognitive disorder


subject: UMLS:C4045537

object_name: mental disorder


subject: UMLS:C4045537

object_name: psychiatric disorder


subject: UMLS:C4045537

object_name: tauopathy


subject: UMLS:C4045537

object_name: Presenile dementia


subject: UMLS:C4045537

object_name: dementia


subject: CHEBI:36791

subject_name: Escitalopram

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:63115

subject_name: Fingolimod

object_name: Depressed mood


subject: CHEBI:63115

object_name: Cancer patients and suicide and depression


subject: CHEBI:63115

object_name: Depressed - symptom


subject: CHEBI:63115

object_name: Depression, CTCAE


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:2948

subject_name: Azathioprine

object_name: EXCESS LMW-DNA


subject: UMLS:C2604387

object_name: acromegaly


subject: UMLS:C2604387

object_name: Acral overgrowth


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: autoimmune hepatitis


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:3360

subject_name: Cannabinol

object_name: epidermolysis bullosa simplex


subject: CHEBI:3360

object_name: junctional epidermolysis bullosa


subject: CHEBI:3360

object_name: epidermolysis bullosa dystrophica


subject: CHEBI:3360

object_name: Kindler syndrome


subject: PUBCHEM.COMPOUND:3222

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:3222

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:3222

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:3222

object_name: venous hemangioma


subject: PUBCHEM.COMPOUND:3222

object_name: Venous malformation


subject: PUBCHEM.COMPOUND:3222

object_name: congenital vascular malformation


subject: PUBCHEM.COMPOUND:3222

object_name: vascular malformation


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:63115

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:63115

object_name: amyotrophic lateral sclerosis


subject: CHEBI:4708

subject_name: Doxazosin

object_name: alcohol dependence


subject: UMLS:C5814454

subject_name: Arexvy

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C5815500


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: hepatitis C


subject: CHEBI:73604

object_name: HIV infection


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: hypersensitivity pneumonitis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8378

subject_name: Prednisolone


subject: UNII:I2CST2BV1Q

object_name: rheumatoid arthritis


subject: CHEBI:102216

subject_name: Methohexital

object_name: atrial fibrillation


subject: CHEBI:102216

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:102216

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:102216

object_name: atrial flutter


subject: CHEBI:102216

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:102216

object_name: Atrial Flutter, CTCAE


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:177833

subject_name: Cilengitide

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0764377


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: melanoma


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:23965

subject_name: estradiol

object_name: Postmenopausal bleeding


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Left atrial appendage thrombosis


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: Cigarette Smoking-Related Carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: tonsillitis


subject: UMLS:C3896947

subject_name: Fluorine F 18 Ara-G

object_name: non-small cell lung carcinoma


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Carcinoma breast stage IV


subject: UMLS:C0169964

subject_name: somatropin

object_name: fetal growth restriction


subject: UNII:K911R84KEW

subject_name: Margetuximab


subject: UNII:K911R84KEW

object_name: HER2 positive breast carcinoma


subject: UNII:K911R84KEW

object_name: Advanced breast cancer


subject: UMLS:C2984521

subject_name: MGAH22 antibody


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:234248D0HH


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1

object_name: Critical Illness


subject: UMLS:C0061355

object_name: hypoglycemia


subject: UMLS:C0061355

object_name: Blood glucose below reference range (finding)


subject: UMLS:C0061355

object_name: Hypoglycemia, CTCAE


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic leiomyosarcoma


subject: CHEBI:72317

object_name: Unresectable Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:72317

object_name: Stage IV Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:72317

object_name: Stage III Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:72317

object_name: Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:72317

object_name: Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:72317

object_name: Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:72317

object_name: Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:72317

object_name: Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: PR:000004266

subject_name: AT-rich interactive domain-containing protein 3B

object_name: asthma


subject: CHEBI:191205

subject_name: Phe-Phe


subject: PUBCHEM.COMPOUND:9919001

subject_name: FORMOTEROL FUMARATE


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Neck Carcinoma


subject: UMLS:C5848866

object_name: head and neck neoplasm


subject: UMLS:C5848866

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL1743086

subject_name: VATELIZUMAB

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C4519597

subject_name: Vatelizumab


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: Confusion


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:135423438

object_name: interstitial lung disease 2


subject: PUBCHEM.COMPOUND:135423438

object_name: Complication of transplanted lung


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: UMLS:C3537265

subject_name: LY573636 sodium

object_name: Childhood Breast Carcinoma


subject: UMLS:C3537265

object_name: breast carcinoma


subject: UMLS:C3537265

object_name: breast cancer


subject: PUBCHEM.COMPOUND:3005835

object_name: non-small cell lung carcinoma


subject: UMLS:C3714249

object_name: type 2 diabetes mellitus


subject: UMLS:C4330852

subject_name: Oligomeric Procyanidin Complex


subject: UMLS:C4330852


subject: UMLS:C4330852


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: cervical cancer


subject: GTOPDB:12966

object_name: cervical polyp


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:63630

subject_name: Tolcapone

object_name: Compulsion


subject: CHEBI:63630

object_name: Osteochondritis


subject: CHEBI:63630


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: metastatic melanoma


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: UMLS:C4725071

object_name: small cell lung carcinoma


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Surgical procedure finding


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: meningioma


subject: CHEBI:50217

subject_name: selegiline

object_name: cannabis abuse


subject: CHEBI:681569

subject_name: Clofarabine

object_name: small intestine cancer


subject: CHEBI:681569

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Chronic Myelomonocytic Leukemia-1


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:1805

object_name: Chronic Myelomonocytic Leukemia-2


subject: PUBCHEM.COMPOUND:1805

object_name: myelodysplastic syndrome with excess blasts


subject: PUBCHEM.COMPOUND:1805

object_name: myelodysplastic syndrome with excess blasts-1


subject: PUBCHEM.COMPOUND:1805

object_name: myelodysplastic syndrome with excess blasts-2


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:63791

object_name: chronic myelomonocytic leukemia


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716

object_name: Myelodysplasia


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: UMLS:C5447481

subject_name: Zimistobart

object_name: non-small cell lung carcinoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:52717

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:52717

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:52717

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Subfertility


subject: CHEBI:74061

subject_name: Ile-Arg

object_name: schizophrenia


subject: CHEBI:74061

object_name: schizoaffective disorder


subject: CHEBI:74061

object_name: schizophrenia 18


subject: CHEBI:49666

subject_name: iridium atom


subject: CHEBI:49666


subject: CHEBI:49666


subject: PR:000009064

subject_name: insulin receptor


subject: PR:000009064


subject: PR:000009064


subject: CHEBI:82978

subject_name: paliperidone


subject: CHEBI:82978


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:83804


subject: UMLS:C2095775

subject_name: ampicillins

object_name: Surgical Wound Infection


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:167638

subject_name: Labetalol

object_name: malignant hypertension


subject: CHEBI:167638

object_name: Hypertensive emergency


subject: CHEBI:167638

object_name: Hypertensive crisis


subject: CHEBI:167638


subject: CHEBI:167638

object_name: preeclampsia postpartum


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: CHEBI:7565


subject: CHEBI:7565


subject: CHEBI:7565


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: congenital heart disease


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:4910

subject_name: Etomidate

object_name: respiratory failure


subject: CHEBI:4910

object_name: Respiratory Failure, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: HER2 positive breast carcinoma


subject: CHEBI:4026

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:4026

object_name: breast adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:41774

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:41774

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:41774


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Postoperative endophthalmitis


subject: UMLS:C3493556

object_name: plasma cell myeloma


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: neoplasm


subject: UMLS:C4287697


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin

object_name: kidney failure


subject: UNII:12M44VTJ7B

subject_name: DALTEPARIN SODIUM


subject: UMLS:C0498888

subject_name: INJECTION, DALTEPARIN SODIUM, PER 2500 IU ADMINISTERED


subject: UMLS:C5700222

subject_name: SDZ MSL 109

object_name: cytomegalovirus retinitis


subject: UMLS:C5700222

object_name: HIV infection


subject: PUBCHEM.COMPOUND:18541918

subject_name: Ampicillin-sulbactam

object_name: Acinetobacter bacteraemia


subject: PUBCHEM.COMPOUND:18541918

object_name: Pneumonia caused by Acinetobacter


subject: PUBCHEM.COMPOUND:18541918

object_name: Infection caused by carbapenem resistant bacteria


subject: CHEBI:51770

subject_name: Sultamicillin


subject: CHEBI:51770


subject: CHEBI:51770


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol


subject: PUBCHEM.COMPOUND:138376495


subject: PUBCHEM.COMPOUND:138376495


subject: CHEBI:8774

subject_name: Ramipril

object_name: hypertension


subject: CHEBI:8774

object_name: Hypertension, CTCAE


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: oligoastrocytoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:66903

subject_name: Vismodegib

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:66903

object_name: Plasma cell myeloma refractory


subject: CHEBI:66903

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:66903

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: Atopic rhinitis


subject: UMLS:C5706513

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:192614

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:192614

object_name: pulmonary arterial hypertension


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:76607

subject_name: Macitentan


subject: CHEBI:76607

object_name: pulmonary hypertension


subject: CHEBI:76607


subject: CHEBI:76607


subject: CHEBI:84491

object_name: melanoma


subject: UNII:O84C90HH2L

subject_name: Poly I-C


subject: CHEBI:73582

subject_name: Leu-Cys


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Surgical procedure finding


subject: UNII:AHU547PI9H

object_name: iron deficiency anemia


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Mantle cell lymphoma stage I


subject: PUBCHEM.COMPOUND:5466794

object_name: Mantle cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:5466794

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:5466794

object_name: Mantle cell lymphoma stage III


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Untreated Hairy Cell Leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: B-cell small lymphocytic lymphoma stage I


subject: PUBCHEM.COMPOUND:5466794

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:5466794

object_name: B-cell small lymphocytic lymphoma stage IV


subject: PUBCHEM.COMPOUND:5466794

object_name: B-cell small lymphocytic lymphoma stage III


subject: PUBCHEM.COMPOUND:5466794

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:5466794

object_name: Marginal zone lymphoma stage I


subject: PUBCHEM.COMPOUND:5466794

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Marginal zone lymphoma stage IV


subject: PUBCHEM.COMPOUND:5466794

object_name: Marginal zone lymphoma stage III


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:5466794

object_name: Chronic lymphocytic leukaemia stage 1


subject: PUBCHEM.COMPOUND:5466794

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:5466794

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:5466794

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:5466794

object_name: Chronic lymphocytic leukaemia stage 2


subject: PUBCHEM.COMPOUND:5466794

object_name: refractory hairy cell leukemia


subject: PUBCHEM.COMPOUND:5466794

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:47344

subject_name: Alvocidib

object_name: Mantle cell lymphoma stage I


subject: CHEBI:47344

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:47344

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:47344

object_name: Mantle cell lymphoma stage III


subject: CHEBI:47344

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:47344

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:47344

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:47344

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:47344

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:47344

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:47344

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:47344

object_name: MALT lymphoma


subject: CHEBI:47344

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:47344

object_name: Marginal zone lymphoma stage I


subject: CHEBI:47344

object_name: splenic marginal zone lymphoma


subject: CHEBI:47344

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:47344

object_name: Marginal zone lymphoma stage III


subject: CHEBI:47344

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:47344

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:47344

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:47344

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:47344

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:47344

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:47344

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:47344

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:47344

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:47344

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:47344

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:47344

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:47344

object_name: refractory hairy cell leukemia


subject: CHEBI:47344

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Mantle cell lymphoma stage I


subject: PUBCHEM.COMPOUND:3368

object_name: Mantle cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:3368

object_name: Mantle cell lymphoma stage III


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Untreated Hairy Cell Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell small lymphocytic lymphoma stage I


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell small lymphocytic lymphoma stage IV


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell small lymphocytic lymphoma stage III


subject: PUBCHEM.COMPOUND:3368

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Marginal zone lymphoma stage I


subject: PUBCHEM.COMPOUND:3368

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Marginal zone lymphoma stage IV


subject: PUBCHEM.COMPOUND:3368

object_name: Marginal zone lymphoma stage III


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Chronic lymphocytic leukaemia stage 1


subject: PUBCHEM.COMPOUND:3368

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:3368

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:3368

object_name: Chronic lymphocytic leukaemia stage 2


subject: PUBCHEM.COMPOUND:3368

object_name: refractory hairy cell leukemia


subject: CHEBI:63599

subject_name: Fludarabine

object_name: Mantle cell lymphoma stage I


subject: CHEBI:63599

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:63599

object_name: Mantle cell lymphoma stage III


subject: CHEBI:63599

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:63599

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:63599

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:63599

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:63599

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:63599

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:63599

object_name: Marginal zone lymphoma stage I


subject: CHEBI:63599

object_name: splenic marginal zone lymphoma


subject: CHEBI:63599

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:63599

object_name: Marginal zone lymphoma stage III


subject: CHEBI:63599

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:63599

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:63599

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:63599

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:63599

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:63599

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:63599

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:63599

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:63599

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:63599

object_name: refractory hairy cell leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:4F4X42SYQ6

object_name: Untreated Hairy Cell Leukemia


subject: UNII:4F4X42SYQ6

object_name: B-cell small lymphocytic lymphoma stage I


subject: UNII:4F4X42SYQ6

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:4F4X42SYQ6

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:4F4X42SYQ6

object_name: Marginal zone lymphoma stage I


subject: UNII:4F4X42SYQ6

object_name: splenic marginal zone lymphoma


subject: UNII:4F4X42SYQ6

object_name: Marginal zone lymphoma stage IV


subject: UNII:4F4X42SYQ6

object_name: Marginal zone lymphoma stage III


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Chronic lymphocytic leukaemia stage 1


subject: UNII:4F4X42SYQ6

object_name: Chronic lymphocytic leukaemia stage 3


subject: UNII:4F4X42SYQ6

object_name: Chronic lymphocytic leukaemia stage 4


subject: UNII:4F4X42SYQ6

object_name: Chronic lymphocytic leukaemia stage 2


subject: UMLS:C0295415

subject_name: rituximab

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C0295415

object_name: Untreated Hairy Cell Leukemia


subject: UMLS:C0295415

object_name: B-cell small lymphocytic lymphoma stage I


subject: UMLS:C0295415

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C0295415

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C0295415

object_name: Marginal zone lymphoma stage I


subject: UMLS:C0295415

object_name: splenic marginal zone lymphoma


subject: UMLS:C0295415

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C0295415

object_name: Marginal zone lymphoma stage III


subject: UMLS:C0295415

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UMLS:C0295415

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UMLS:C0295415

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UMLS:C0295415

object_name: Chronic lymphocytic leukaemia stage 1


subject: UMLS:C0295415

object_name: Chronic lymphocytic leukaemia stage 3


subject: UMLS:C0295415

object_name: Chronic lymphocytic leukaemia stage 4


subject: UMLS:C0295415

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:91899

object_name: Severe Acute Malnutrition


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:506227

subject_name: N-acetyl-D-glucosamine


subject: CHEBI:28009

subject_name: N-Acetylglucosamine


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide


subject: UMLS:C1098514


subject: CHEBI:7553

subject_name: Niclosamide


subject: CHEBI:7553

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: CHEBI:125628

subject_name: Alisertib

object_name: Mesothelioma


subject: CHEBI:125628

object_name: mesothelial neoplasm


subject: CHEBI:125628

object_name: malignant mesothelioma


subject: CHEBI:125628

object_name: lung cancer


subject: CHEBI:125628

object_name: lung neoplasm


subject: CHEBI:125628

object_name: lung carcinoma


subject: CHEBI:31237

subject_name: Vesnarinone

object_name: HIV infection


subject: CHEBI:230386

subject_name: Pimonidazole

object_name: prostate carcinoma


subject: CHEBI:230386

object_name: prostate cancer


subject: UNII:721809WQCP

subject_name: Ruboxistaurin

object_name: type 1 diabetes mellitus 1


subject: UNII:721809WQCP

object_name: type 1 diabetes mellitus


subject: UNII:721809WQCP

object_name: type 2 diabetes mellitus


subject: CHEBI:39669

subject_name: Diflunisal


subject: UMLS:C4683552

object_name: melanoma


subject: UMLS:C4683552

object_name: skin neoplasm


subject: UMLS:C4683552

object_name: skin cancer


subject: UMLS:C2352589

object_name: Alzheimer disease 2


subject: UMLS:C2352589

object_name: Alzheimer Disease, Late Onset


subject: CHEBI:79033

subject_name: florbetaben F18


subject: CHEBI:79033


subject: UNII:BMO5G62HGB

subject_name: FLORBETABEN


subject: UNII:BMO5G62HGB


subject: CHEBI:15354

subject_name: Choline

object_name: lymphangioleiomyomatosis


subject: CHEBI:15354

object_name: lung lymphangioleiomyomatosis


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: neuralgia


subject: PUBCHEM.COMPOUND:4715169

object_name: Neuropathic pain


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: PUBCHEM.COMPOUND:3080727

object_name: pertussis


subject: PUBCHEM.COMPOUND:3080727

object_name: tetanus


subject: PUBCHEM.COMPOUND:3080727

object_name: diphtheria


subject: PUBCHEM.COMPOUND:3080727

object_name: meningococcemia


subject: PUBCHEM.COMPOUND:3080727

object_name: meningitis


subject: PUBCHEM.COMPOUND:3080727

object_name: Meningitis, CTCAE


subject: UMLS:C0087554

subject_name: (dApT)


subject: UMLS:C0087554


subject: UMLS:C0087554


subject: UMLS:C0087554


subject: UMLS:C0087554


subject: UMLS:C0087554


subject: UMLS:C3644171

subject_name: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed


subject: UMLS:C3644171


subject: UMLS:C3644171


subject: UMLS:C3644171


subject: UMLS:C3644171


subject: UMLS:C3644171


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: diffuse large B-cell lymphoma


subject: UNII:KXG2PJ551I

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:KXG2PJ551I

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: GTOPDB:9244

subject_name: utomilumab


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Zinc deficiency


subject: CHEBI:85993

subject_name: Palbociclib

object_name: pancreatic endocrine carcinoma


subject: UMLS:C3640969

subject_name: Recombinant dimeric g-csf fusion protein f627

object_name: Childhood Breast Carcinoma


subject: UMLS:C3640969

object_name: breast carcinoma


subject: UMLS:C3640969

object_name: breast cancer


subject: PUBCHEM.COMPOUND:67177778


subject: PUBCHEM.COMPOUND:67177778

object_name: Disorder related to renal transplantation


subject: PUBCHEM.COMPOUND:67177778

object_name: viral disease


subject: CHEBI:68481

subject_name: mTOR inhibitor


subject: CHEBI:68481


subject: CHEBI:68481


subject: UMLS:C2746052

subject_name: MTOR Inhibitors


subject: UMLS:C2746052


subject: UMLS:C2746052


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:N19A0T0E5J

object_name: acute myeloid leukemia


subject: UNII:N19A0T0E5J

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:N19A0T0E5J

object_name: acute lymphoblastic leukemia


subject: UNII:N19A0T0E5J

object_name: myelofibrosis


subject: UNII:N19A0T0E5J

object_name: aplastic anemia


subject: UNII:N19A0T0E5J

object_name: Hodgkin Disease


subject: UNII:N19A0T0E5J

object_name: adult lymphoma


subject: UNII:N19A0T0E5J

object_name: lymphoma


subject: UNII:N19A0T0E5J

object_name: pediatric lymphoma


subject: CHEBI:135983

subject_name: Teriparatide


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: CHEBI:135983


subject: UMLS:C5139893

subject_name: gedivumab

object_name: influenza


subject: UMLS:C5139963


subject: CHEBI:2663

subject_name: Amiodarone

object_name: post-operative atrial fibrillation


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:50659

subject_name: Dronedarone


subject: MESH:D000954

subject_name: Antigens, Surface


subject: UMLS:C3896931

object_name: biliary tract cancer


subject: UMLS:C3896931

object_name: carcinoma of the ampulla of vater


subject: UMLS:C3896931

object_name: gallbladder cancer


subject: UMLS:C3896931

object_name: cholangiocarcinoma


subject: UMLS:C3896931

object_name: liver carcinoma


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: osteoarthritis, hip


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Episodic migraine


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UNII:B6E7K36KT8

subject_name: Cenegermin

object_name: Neurogenic ulcer


subject: UNII:B6E7K36KT8

object_name: Neuropathic corneal ulcer


subject: UNII:B6E7K36KT8

object_name: neurotrophic keratoconjunctivitis


subject: UMLS:C3181874

object_name: Chronic uremia


subject: CHEBI:72296

subject_name: Apixaban

object_name: portal hypertension


subject: CHEBI:72296

object_name: Cirrhosis


subject: CHEBI:72296

object_name: liver cirrhosis


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:4653


subject: CHEBI:4653


subject: CHEBI:4653

object_name: thrombophilia due to thrombin defect


subject: CHEBI:4653

object_name: Venous thrombosis after immobility


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: migraine


subject: UNII:PF8K38CG54

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: esophageal adenocarcinoma


subject: UNII:K16AIQ8CTM

object_name: carcinoma of esophagus


subject: UNII:K16AIQ8CTM

object_name: esophageal cancer


subject: UNII:K16AIQ8CTM

object_name: Childhood Esophageal Carcinoma


subject: UNII:K16AIQ8CTM

object_name: neoplasm of esophagus


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:91951

object_name: Solid Neoplasm


subject: CHEBI:91951

object_name: triple-negative breast carcinoma


subject: CHEBI:91951

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:91951

object_name: prostate cancer


subject: CHEBI:91951

object_name: ovarian cancer


subject: CHEBI:91951

object_name: ovarian neoplasm


subject: CHEBI:91951

object_name: ovarian carcinoma


subject: CHEBI:91951

object_name: breast disorder


subject: CHEBI:91951

object_name: cervical cancer


subject: CHEBI:91951

object_name: endometrial cancer


subject: CHEBI:91951

object_name: uterine corpus cancer


subject: CHEBI:91951

object_name: endometrial carcinoma


subject: CHEBI:91951

object_name: female reproductive system neoplasm


subject: CHEBI:91951

object_name: prostate carcinoma


subject: CHEBI:91951

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:91951

object_name: endometrium neoplasm


subject: CHEBI:91951

object_name: uterine cancer


subject: CHEBI:91951

object_name: tumor of uterus


subject: CHEBI:91951

object_name: suppressor of tumorigenicity 3


subject: CHEBI:91951

object_name: cervical carcinoma


subject: CHEBI:91951

object_name: cervical polyp


subject: CHEBI:91951

object_name: malignant epithelial tumor of ovary


subject: CHEBI:91951

object_name: cancer


subject: CHEBI:91951

object_name: neoplasm


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:17756771

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:17756771

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:17756771

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: breast disorder


subject: PUBCHEM.COMPOUND:17756771

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: female reproductive system neoplasm


subject: PUBCHEM.COMPOUND:17756771

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Neoplasm of the genitourinary tract


subject: PUBCHEM.COMPOUND:17756771

object_name: endometrium neoplasm


subject: PUBCHEM.COMPOUND:17756771

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:17756771

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:17756771

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: cervical polyp


subject: PUBCHEM.COMPOUND:17756771

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:17756771

object_name: cancer


subject: PUBCHEM.COMPOUND:17756771

object_name: neoplasm


subject: CHEBI:78739

subject_name: Emodepside

object_name: filariasis


subject: CHEBI:78739

object_name: Infection by Filaroides


subject: UMLS:C1098962


subject: UMLS:C1098962


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Terlipressin adverse reaction


subject: CHEBI:91834

subject_name: Articaine

object_name: periodontitis


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:194548

subject_name: Racepinephrine


subject: UMLS:C1512523

subject_name: hydrochloride


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Hand muscle strain


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Low back pain


subject: CHEMBL.COMPOUND:CHEMBL5095274

object_name: Netherton syndrome


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Infection of heart transplant


subject: UMLS:C1881373

object_name: Cardiac transplant failure


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: bladder neck obstruction


subject: PUBCHEM.COMPOUND:18319735

object_name: lower urinary tract symptom


subject: CHEBI:3215

subject_name: Bupivacaine


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Sepsis


subject: UNII:PP0SHH6V16

object_name: Sepsis, CTCAE


subject: GTOPDB:8086

subject_name: bimagrumab

object_name: Overweight


subject: GTOPDB:8086

object_name: obesity due to melanocortin 4 receptor deficiency


subject: GTOPDB:8086

object_name: obesity


subject: GTOPDB:8086

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3137353

subject_name: BIMAGRUMAB


subject: CHEMBL.COMPOUND:CHEMBL3137353


subject: CHEMBL.COMPOUND:CHEMBL3137353


subject: CHEMBL.COMPOUND:CHEMBL3137353


subject: UMLS:C3896893


subject: UMLS:C3896893


subject: UMLS:C3896893


subject: UMLS:C3896893


subject: UMLS:C3831455

object_name: adrenal carcinoma


subject: UMLS:C3831455

object_name: adrenal cortex carcinoma


subject: UMLS:C3831455

object_name: Adrenal Cancer


subject: UMLS:C3831455

object_name: corpus callosum, agenesis of


subject: UMLS:C3831455

object_name: Congenital scar


subject: CHEBI:50838

subject_name: Drospirenone

object_name: neural tube defect


subject: CHEBI:50838

object_name: neural tube defects, susceptibility to


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: PUBCHEM.COMPOUND:136126080

subject_name: Methyltetrahydrofolate

object_name: Uses contraception (finding)


subject: PUBCHEM.COMPOUND:136126080


subject: PUBCHEM.COMPOUND:136126080


subject: PUBCHEM.COMPOUND:136025184

subject_name: Methyltetrahydrofolic acid


subject: PUBCHEM.COMPOUND:136025184


subject: PUBCHEM.COMPOUND:136025184


subject: CHEBI:25345

subject_name: methyltetrahydrofolate


subject: CHEBI:25345


subject: CHEBI:25345


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: acute graft versus host disease


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:25CC4N0P8J

subject_name: NALFURAFINE HYDROCHLORIDE

object_name: Uremic pruritus


subject: CHEBI:136019

subject_name: Nalfurafine


subject: UMLS:C1610428

subject_name: nalfurafine hydrochloride


subject: CHEBI:34741

subject_name: Equol

object_name: benign prostatic hyperplasia


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: rabies


subject: CHEBI:134708

subject_name: Saroglitazar

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:134708

object_name: Complication of transplanted liver


subject: UMLS:C4725689

subject_name: EP4 Antagonist ONO-4578

object_name: Her2-receptor negative breast cancer


subject: UMLS:C4725689

object_name: hormone receptor-positive breast cancer


subject: UMLS:C4725689

object_name: Carcinoma breast stage IV


subject: UMLS:C4725689

object_name: Breast cancer recurrent


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:233362

subject_name: Abemaciclib


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:233362


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:29013

subject_name: Fusidic acid

object_name: seborrheic keratosis


subject: CHEBI:29013

object_name: skin tag


subject: CHEBI:29013

object_name: fibroepithelial polyp


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: non-small cell lung carcinoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C4330031

subject_name: Gallium Ga 68 P15-041

object_name: metastatic prostate carcinoma


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA


subject: CHEBI:85274

subject_name: Pristinamycin

object_name: tonsillitis


subject: PUBCHEM.COMPOUND:122731

subject_name: Virginiamycin


subject: UMLS:C0205996

subject_name: pristinamycin


subject: UMLS:C1312368

object_name: arteriosclerosis disorder


subject: UMLS:C1312368

object_name: atherosclerosis


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: PUBCHEM.COMPOUND:11154555

subject_name: Cariprazine

object_name: bipolar I disorder


subject: PUBCHEM.COMPOUND:11154555

object_name: Mania, CTCAE


subject: PUBCHEM.COMPOUND:11154555

object_name: Mania


subject: CHEBI:90933


subject: CHEBI:90933


subject: CHEBI:90933


subject: UNII:2WTV10SIKH

subject_name: Mitapivat

object_name: pyruvate kinase deficiency of red cells


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: hyperinsulinism


subject: UMLS:C3714501

object_name: Hyperinsulinemia


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: myocardial infarction


subject: UNII:WGD229O42W

object_name: Myocardial Infarction, CTCAE


subject: UNII:WGD229O42W

object_name: Myocardial Infarction by ECG Finding


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: endogenous depression


subject: UNII:PF8K38CG54

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:6912

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:6912

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:6912

object_name: Oral Mucositis


subject: PUBCHEM.COMPOUND:6912

object_name: stomatitis


subject: PUBCHEM.COMPOUND:6912

object_name: oral mucositis


subject: PUBCHEM.COMPOUND:6912

object_name: mucositis


subject: PUBCHEM.COMPOUND:6912

object_name: Radiation Sickness


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:41139

subject_name: BETAINE


subject: CHEBI:41139


subject: CHEBI:41139


subject: CHEBI:41139


subject: CHEBI:41139


subject: CHEBI:41139


subject: CHEBI:41139


subject: CHEBI:41139


subject: CHEBI:72296

subject_name: Apixaban

object_name: Left Ventricular Thrombus Related to COVID-19


subject: CHEBI:72296

object_name: Left ventricular thrombus


subject: CHEBI:72296

object_name: acute myocardial infarction


subject: CHEBI:72296

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:9XW757O13D

subject_name: Ripretinib

object_name: Plexosarcoma


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:3311

object_name: obesity


subject: CHEBI:3311

object_name: Obesity, CTCAE


subject: DRUGBANK:DB11097

subject_name: Plantago seed


subject: DRUGBANK:DB11097


subject: DRUGBANK:DB11097


subject: CHEBI:165446

subject_name: Psyllic acid


subject: CHEBI:165446


subject: CHEBI:165446


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Malignant Paraganglioma


subject: CHEBI:72317

object_name: Unresectable Paraganglioma


subject: CHEBI:72317

object_name: Unresectable Adrenal Gland Pheochromocytoma


subject: CHEBI:72317

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:72317

object_name: Locally Advanced Paraganglioma


subject: CHEBI:72317

object_name: Regional Adrenal Gland Pheochromocytoma


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Drug Metabolism, Poor, CYP2C19-Related


subject: CHEBI:68558

object_name: artery disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Invasive fungal infection


subject: UMLS:C0700805

subject_name: Fludara

object_name: adult lymphoma


subject: UMLS:C0700805

object_name: lymphoma


subject: UMLS:C0700805

object_name: pediatric lymphoma


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: relapsing-remitting multiple sclerosis


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: myelofibrosis


subject: UMLS:C1831941

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C1831941

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: autosomal dominant hypocalcemia


subject: CHEBI:41879

object_name: Hypocalcemia


subject: CHEBI:41879

object_name: Serum calcium below normal (finding)


subject: CHEBI:41879

object_name: Hypocalcemia, CTCAE


subject: CHEBI:41879

object_name: voice disorders


subject: CHEBI:41879

object_name: Voice Alteration


subject: CHEBI:134267

subject_name: 3,5-diiodothyropropionic acid

object_name: Hypercholesterolemia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Consciousness related finding


subject: CHEBI:4466

object_name: Neurological status: consciousness


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6121

object_name: Coma


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931

object_name: Unconsciousness


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:15365

subject_name: Aspirin

object_name: Angina pectoris


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:37941

object_name: arteriosclerosis disorder


subject: CHEBI:37941

object_name: atherosclerosis


subject: UMLS:C5238081

subject_name: Bucelipase alfa

object_name: cystic fibrosis


subject: UMLS:C5238081

object_name: exocrine pancreatic insufficiency


subject: CHEBI:5558

subject_name: Guanfacine

object_name: schizotypal personality disorder


subject: CHEBI:5558

object_name: Symphysis Pubis Dysfunction


subject: CHEBI:5558

object_name: synpolydactyly


subject: CHEBI:63631

subject_name: Topiramate

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:63631

object_name: metabolic syndrome X


subject: CHEBI:63631

object_name: schizophrenia


subject: CHEBI:37941

object_name: disease susceptibility


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Refractory Leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:8364

subject_name: Prazosin

object_name: autonomic dysreflexia


subject: CHEBI:44241

subject_name: Metyrapone

object_name: cocaine dependence


subject: CHEBI:29033

subject_name: Ferrous cation


subject: CHEBI:7823

subject_name: Oxazepam


subject: CHEBI:137359

object_name: Critical Illness


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: UMLS:C3864383

subject_name: Lumason

object_name: coronary artery disorder


subject: UMLS:C3864383

object_name: coronary atherosclerosis


subject: UMLS:C0796512

subject_name: CCI 779

object_name: plasma cell myeloma


subject: CHEBI:79699

subject_name: Temsirolimus


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan

object_name: Metastatic non-small cell lung cancer


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Sedation


subject: CHEBI:119915

object_name: Sedated


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: cardiac allograft vasculopathy


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: cytomegalovirus infection


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:62932

subject_name: mycophenolate


subject: CHEBI:62932


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:231350

subject_name: Pacritinib

object_name: graft versus host disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Barrett esophagus


subject: CHEBI:8499

subject_name: Propranolol

object_name: primary progressive aphasia


subject: CHEBI:8499

object_name: GRN-related frontotemporal lobar degeneration with Tdp43 inclusions


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:5281767

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:5281767

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:5281767

object_name: Cardiovascular Risk


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: dry eye syndrome


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: acute thrombosis of deep veins of lower extremity


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Lyme disease


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: mantle cell lymphoma


subject: CHEBI:50513

subject_name: mydriatic agent

object_name: diabetic retinopathy


subject: CHEBI:50513

object_name: diabetic macular edema


subject: CHEBI:50513

object_name: diabetic eye disease


subject: UMLS:C0026964

subject_name: Mydriatics


subject: UMLS:C0026964


subject: UMLS:C0026964


subject: PUBCHEM.COMPOUND:3367

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694


subject: CHEBI:4305

subject_name: dacarbazine

object_name: melanoma


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UNII:PJX9GH268R


subject: CHEBI:50730

subject_name: Montelukast


subject: CHEBI:42446

subject_name: Esflurbiprofen


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:6931

subject_name: Midazolam


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:63660


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Primary human immunodeficiency virus infection


subject: CHEBI:63717

object_name: Sexually transmitted infections (excluding HIV and hepatitis)


subject: CHEBI:63717

object_name: viral hepatitis


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: DRUGBANK:DB10989

subject_name: Hepatitis A Vaccine

object_name: HIV infection


subject: UMLS:C0170300

subject_name: Hepatitis A Vaccines


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: LABOR PRETERM REQUIRING HOSPITALIZATION


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Adhesive Capsulitis


subject: UNII:2S9ZZM9Q9V

object_name: frozen shoulder


subject: UNII:2S9ZZM9Q9V

object_name: bursitis


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: colorectal cancer


subject: UMLS:C4086499

object_name: colorectal carcinoma


subject: UMLS:C4086499

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Radiation mucositis


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Postoperative confusion


subject: PR:000007084

subject_name: mitochondrial enolase superfamily member 1

object_name: Plasmodium falciparum malaria


subject: PR:000022308

subject_name: pantothenate kinase


subject: PR:000013861

subject_name: ATP-dependent DNA helicase Q4


subject: UniProtKB:P0A6I3

subject_name: COAA_ECOLI Pantothenate kinase (sprot)


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:49662

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:49662

object_name: stage IVB rectal cancer


subject: CHEBI:49662

object_name: stage IVA rectal cancer


subject: CHEBI:49662

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:49662

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:49662

object_name: Recurrent Rectal Cancer


subject: CHEBI:49662

object_name: stage IVA colon cancer


subject: CHEBI:49662

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:49662

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:49662

object_name: stage IVB colon cancer


subject: CHEBI:49662

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:49662

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:49662

object_name: Colon cancer recurrent


subject: CHEBI:49662

object_name: colon mucinous adenocarcinoma


subject: CHEBI:49662

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:49662

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:49662

object_name: rectal signet ring cell adenocarcinoma


subject: UMLS:C3539881

subject_name: gamma-interferon

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UMLS:C3539881

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C3539881

object_name: stage IVB rectal cancer


subject: UMLS:C3539881

object_name: stage IVA rectal cancer


subject: UMLS:C3539881

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C3539881

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C3539881

object_name: Recurrent Rectal Cancer


subject: UMLS:C3539881

object_name: stage IVA colon cancer


subject: UMLS:C3539881

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C3539881

object_name: Stage IVA Colon Cancer AJCC v8


subject: UMLS:C3539881

object_name: stage IVB colon cancer


subject: UMLS:C3539881

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C3539881

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C3539881

object_name: Colon cancer recurrent


subject: UMLS:C3539881

object_name: colon mucinous adenocarcinoma


subject: UMLS:C3539881

object_name: colon signet ring cell adenocarcinoma


subject: UMLS:C3539881

object_name: rectum mucinous adenocarcinoma


subject: UMLS:C3539881

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:41500

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:41500

object_name: stage IVB rectal cancer


subject: CHEBI:41500

object_name: stage IVA rectal cancer


subject: CHEBI:41500

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:41500

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:41500

object_name: Recurrent Rectal Cancer


subject: CHEBI:41500

object_name: stage IVA colon cancer


subject: CHEBI:41500

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:41500

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:41500

object_name: stage IVB colon cancer


subject: CHEBI:41500

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:41500

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:41500

object_name: Colon cancer recurrent


subject: CHEBI:41500

object_name: colon mucinous adenocarcinoma


subject: CHEBI:41500

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:41500

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:41500

object_name: rectal signet ring cell adenocarcinoma


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: metastatic melanoma


subject: CHEBI:38940

subject_name: Sunitinib


subject: PUBCHEM.COMPOUND:54760385

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:54760385

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:54760385

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: abdominal obesity-metabolic syndrome


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: metabolic syndrome X


subject: DRUGBANK:DB16615

subject_name: Krill oil


subject: DRUGBANK:DB16615


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Stomach cancer


subject: UMLS:C4086713

object_name: gastric cancer


subject: CHEBI:177298

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IIC Prostate Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: CHEBI:177298

object_name: prostate adenocarcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:16899

subject_name: Mannitol

object_name: kidney neoplasm


subject: CHEBI:16899

object_name: kidney cancer


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: lung cancer


subject: UMLS:C0071315

object_name: lung neoplasm


subject: UMLS:C0071315

object_name: lung carcinoma


subject: UMLS:C0071315

object_name: Childhood Breast Carcinoma


subject: UMLS:C0071315

object_name: breast carcinoma


subject: UMLS:C0071315

object_name: breast cancer


subject: UMLS:C0071315

object_name: prostate carcinoma


subject: UMLS:C0071315

object_name: prostate cancer


subject: UNII:86EEZ49YVB

subject_name: FOSTAMATINIB DISODIUM

object_name: autoimmune hemolytic anemia, warm type


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib


subject: UNII:BI009E452R

subject_name: Andexanet alfa

object_name: Hemorrhage


subject: UMLS:C4045506


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: cancer


subject: CHEBI:107736

object_name: neoplasm


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: liver cirrhosis


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Closed Fracture


subject: CHEBI:60802

object_name: Fractured humerus


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C3827082


subject: CHEMBL.COMPOUND:CHEMBL2109616

object_name: chronic bronchitis


subject: CHEMBL.COMPOUND:CHEMBL2109616

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL2109616

object_name: chronic obstructive pulmonary disease


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:11531537

subject_name: Eliglustat

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:11531537

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:11531537

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors


subject: MESH:D000082082


subject: MESH:D000082082


subject: UMLS:C3899687

subject_name: ChiNing Decoction

object_name: Neck Carcinoma


subject: UMLS:C3899687

object_name: head and neck neoplasm


subject: UMLS:C3899687

object_name: head and neck cancer


subject: UMLS:C5854404

subject_name: Anti-BCMA/GPRC5D/CD3 Trispecific Antibody JNJ-79635322

object_name: plasma cell myeloma


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Graves disease


subject: CHEBI:8378

object_name: hyperthyroidism


subject: CHEBI:8378

object_name: Hyperthyroidism, CTCAE


subject: UMLS:C5943222

object_name: HIV infection


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: coronary artery disorder


subject: CHEBI:36333

object_name: coronary atherosclerosis


subject: CHEBI:36333

object_name: Catheter site pain


subject: CHEBI:36333

object_name: Catheter site discomfort


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: UMLS:C3536836


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: CHEBI:474053

subject_name: Cefazolin

object_name: endometritis


subject: UMLS:C2987425

subject_name: mavrilimumab

object_name: rheumatoid arthritis


subject: CHEBI:233453


subject: CHEBI:233453

object_name: genital herpes


subject: CHEBI:233453

object_name: Genital herpes male


subject: CHEBI:233453

object_name: genital herpes in women


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:83766

subject_name: Olaparib

object_name: Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UNII:92VV7G83ED

subject_name: anavip

object_name: Snake Bites


subject: UNII:92VV7G83ED

object_name: Snake bite (morphologic abnormality)


subject: UNII:92VV7G83ED

object_name: reported bite by snake (history)


subject: UNII:92VV7G83ED

object_name: blood coagulation disease


subject: UNII:M3WGS532VY

object_name: Sedation


subject: UNII:M3WGS532VY

object_name: Sedated


subject: UNII:M3WGS532VY

object_name: no feeling or sensation of skin


subject: UNII:M3WGS532VY

object_name: Sensory Loss


subject: CHEBI:174615

object_name: T-Cell Lymphoma


subject: CHEBI:174615

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:174615

object_name: Hodgkin Disease


subject: CHEBI:174615

object_name: Lymphoma, Low-Grade


subject: CHEBI:174615

object_name: mantle cell lymphoma


subject: CHEBI:174615

object_name: diffuse large B-cell lymphoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681